Health Law Navigator – Pharmaceutical Pricing in 2026: Dramatic Changes or More of the Same?

Several legal developments related to pharmaceutical pricing in 2026 have had the industry scrambling to understand and calculate the impacts. From the implementation of a negotiated “maximum fair price” for selected top selling products to efforts toward “most favored nation” pricing for all to a push to direct-to-consumer offerings to varied state laws to the uncertainty of federal action related to the 340B program and regulating pharmacy benefit managers, industry stakeholders expected 2026 to be a tumultuous year. In this presentation, we outline the legal underpinnings of these dynamics and check in on impacts and what to expect going forward.

Wednesday, March 11, 2026 | 12:00 PM - 1:00 PM
(UTC-05:00) Central Time (US & Canada)

Hosted on Zoom

Attendee
Name Start Time Timezone
Health Law Navigator – Pharmaceutical Pricing in 2026: Dramatic Changes or More of the Same?12:00 PMCDT

Continuing Legal Education (CLE) credits are pending in Arizona, California, Colorado, Florida, Kansas (Once Kansas is approved, it will be a qualified jurisdiction for New York credit), Minnesota, Missouri, Nebraska, Nevada, New Mexico, Oklahoma, Tennessee, Texas, and Utah. CLE credit application and approval processes vary per state and may not be available after certain state deadlines. Please email education@spencerfane.com if you have questions about credits.